Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 2:45 pm Purchase |
2023-12-31 | 13G | Entero Therapeutics, Inc. ENTO |
Armistice Capital, LLC | 78,061 4.990% |
78,061 (New Position) |
Filing History |
| 2023-02-14 12:43 pm Purchase |
2022-12-31 | 13G | First Wave BioPharma, Inc. FWBI |
Armistice Capital, LLC | 37,020 9.990% |
37,020 (New Position) |
Filing History |
| 2021-02-10 09:54 am Purchase |
2021-01-12 | 13D | AzurRx BioPharma, Inc. AZRX |
Ross Edmund Burke Jr. | 309,657 5.890% |
24,914 (+8.75%) |
Filing History |
| 2020-08-11 4:05 pm Purchase |
2020-07-16 | 13D | AzurRx BioPharma, Inc. AZRX |
Ross Edmund Burke Jr. | 284,743 9.990% |
17,006 (+6.35%) |
Filing History |